drugset / Trial / NCT05880849
Choline Effects - Pre-symptomatic AD
Phase 1
Completed
15 enrolled
Paul E Schulz
Balchem Corporation · collabM.D. Anderson Cancer Center · collabMassachusetts Institute of Technology · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test the safety, tolerability, and effects of choline in people with increased risk of Alzheimer's Disease (AD), also known as pre-symptomatic AD. Choline is a dietary supplement, but is being investigated to see if it has any effects on the progression to AD.
Timeline
- Start
- 2023-06-26
- Primary completion
- 2025-07-01
- Completion
- 2025-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Choline | Other / unclassified | 2.2 g | Oral |